Given that mutp53 tumor cell growth is more likely to succumb to mitotic catastrophe if the G2 checkpoint and accumulated DNA damage is ignored, Wee1 inhibitors have posed as particularly intriguing therapeutic strategies towards achieving the aforementioned preferential sensitization of mutp53 cancer cells (23, 25). Here, WEE1 is linked to cancer.